Humacyte, Inc. (HUMA) insider trading
Humacyte, Inc. insiders have made 1 open-market purchase worth $6k since Sep 15, 2026, by 1 insider. The latest: Keith Anthony Jones (Director) bought $6k, filed Sep 15, 2026, scored 30 out of 100.
Follow HUMA, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 15 Form 4 (opens sec.gov) |
Keith Anthony JonesDirectorDirector · Penny stock: hard to trade | +25% stake | 30 | $6k 10,000 at $0.56 |
— | — |
HUMA trades reported by members of Congress
| Reported | Member | Trade | Amount |
|---|---|---|---|
| Aug 5 |  Tommy TubervilleR-AL · Senate824 days after the trade | Sale | $1K–$15K |
| Aug 5 | Tommy TubervilleR-AL · Senate824 days after the trade | Sale | $15K–$50K |
| Aug 5 | Tommy TubervilleR-AL · Senate867 days after the trade | Buy | $1K–$15K |
| Aug 5 | Tommy TubervilleR-AL · Senate867 days after the trade | Buy | $15K–$50K |
Members of Congress report trades up to 45 days later, in dollar ranges. Every member's trades.
Insiders who bought HUMA
- Keith Anthony Jones Director
Questions
Are insiders buying HUMA stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $6k.
Who bought HUMA stock most recently?
Keith Anthony Jones, Director, bought 10,000 shares for $6k (Form 4 (opens sec.gov), filed Sep 15, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Sep 15, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer